Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2028)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Anti-Inflammatory Therapeutics Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Anti-Inflammatory Therapeutics Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Anti-Inflammatory Therapeutics Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Anti-Inflammatory Therapeutics Market-Segmentation by Type
5.1 Anti-inflammatory Biologics
5.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
5.3 Corticosteroids
5.4 Other Anti-Inflammatory Drugs
6 Global Anti-Inflammatory Therapeutics Market-Segmentation by Application
6.1 Arthritis
6.2 Respiratory Diseases
6.3 Multiple Sclerosis
6.4 Psoriasis
6.5 Inflammatory Bowel Disease (IBD)
6.6 Other Inflammatory Diseases
7 Global Anti-Inflammatory Therapeutics Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence - Company Profiles
8.1 Hoffmann-La Roche
8.1.1 Hoffmann-La Roche Profile
8.1.2 Hoffmann-La Roche Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Hoffmann-La Roche Product/Solution Launches and Enhancements Analysis
8.1.4 Hoffmann-La Roche Business Overview/Recent Development/Acquisitions
8.2 Pfizer
8.2.1 Pfizer Profile
8.2.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Pfizer Product/Solution Launches and Enhancements Analysis
8.2.4 Pfizer Business Overview/Recent Development/Acquisitions
8.3 Johnson & Johnson
8.3.1 Johnson & Johnson Profile
8.3.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
8.3.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
8.4 Amgen
8.4.1 Amgen Profile
8.4.2 Amgen Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Amgen Product/Solution Launches and Enhancements Analysis
8.4.4 Amgen Business Overview/Recent Development/Acquisitions
8.5 AbbVie
8.5.1 AbbVie Profile
8.5.2 AbbVie Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 AbbVie Product/Solution Launches and Enhancements Analysis
8.5.4 AbbVie Business Overview/Recent Development/Acquisitions
8.6 Eli Lily and Company
8.6.1 Eli Lily and Company Profile
8.6.2 Eli Lily and Company Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Eli Lily and Company Product/Solution Launches and Enhancements Analysis
8.6.4 Eli Lily and Company Business Overview/Recent Development/Acquisitions
8.7 AstraZeneca
8.7.1 AstraZeneca Profile
8.7.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 AstraZeneca Product/Solution Launches and Enhancements Analysis
8.7.4 AstraZeneca Business Overview/Recent Development/Acquisitions
8.8 Merck & Co.
8.8.1 Merck & Co. Profile
8.8.2 Merck & Co. Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Merck & Co. Product/Solution Launches and Enhancements Analysis
8.8.4 Merck & Co. Business Overview/Recent Development/Acquisitions
8.9 GlaxoSmithKline
8.9.1 GlaxoSmithKline Profile
8.9.2 GlaxoSmithKline Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 GlaxoSmithKline Product/Solution Launches and Enhancements Analysis
8.9.4 GlaxoSmithKline Business Overview/Recent Development/Acquisitions
8.10 Novartis
8.10.1 Novartis Profile
8.10.2 Novartis Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Novartis Product/Solution Launches and Enhancements Analysis
8.10.4 Novartis Business Overview/Recent Development/Acquisitions
9 Global Anti-Inflammatory Therapeutics Market-Segmentation by Geography
10 North America
10.1 North America Anti-Inflammatory Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Anti-Inflammatory Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Anti-Inflammatory Therapeutics Production Analysis from 2015-2020
10.4 North America Anti-Inflammatory Therapeutics Consumption Analysis from 2015-2020
10.5 North America Anti-Inflammatory Therapeutics Import and Export from 2015-2020
10.6 North America Anti-Inflammatory Therapeutics Value, Production and Market Share by Type (2015-2020)
10.7 North America Anti-Inflammatory Therapeutics Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Anti-Inflammatory Therapeutics by Country (United States, Canada)
10.8.1 North America Anti-Inflammatory Therapeutics Sales by Country (2015-2020)
10.8.2 North America Anti-Inflammatory Therapeutics Consumption Value by Country (2015-2020)
10.9 North America Anti-Inflammatory Therapeutics Market PEST Analysis
11 Europe
11.1 Europe Anti-Inflammatory Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Anti-Inflammatory Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Anti-Inflammatory Therapeutics Production Analysis from 2015-2020
11.4 Europe Anti-Inflammatory Therapeutics Consumption Analysis from 2015-2020
11.5 Europe Anti-Inflammatory Therapeutics Import and Export from 2015-2020
11.6 Europe Anti-Inflammatory Therapeutics Value, Production and Market Share by Type (2015-2020)
11.7 Europe Anti-Inflammatory Therapeutics Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Anti-Inflammatory Therapeutics by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Anti-Inflammatory Therapeutics Sales by Country (2015-2020)
11.8.2 Europe Anti-Inflammatory Therapeutics Consumption Value by Country (2015-2020)
11.9 Europe Anti-Inflammatory Therapeutics Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Anti-Inflammatory Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Anti-Inflammatory Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Anti-Inflammatory Therapeutics Production Analysis from 2015-2020
12.4 Asia-Pacific Anti-Inflammatory Therapeutics Consumption Analysis from 2015-2020
12.5 Asia-Pacific Anti-Inflammatory Therapeutics Import and Export from 2015-2020
12.6 Asia-Pacific Anti-Inflammatory Therapeutics Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Anti-Inflammatory Therapeutics Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Anti-Inflammatory Therapeutics by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Anti-Inflammatory Therapeutics Sales by Country (2015-2020)
12.8.2 Asia-Pacific Anti-Inflammatory Therapeutics Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Anti-Inflammatory Therapeutics Market PEST Analysis
13 Latin America
13.1 Latin America Anti-Inflammatory Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Anti-Inflammatory Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Anti-Inflammatory Therapeutics Production Analysis from 2015-2020
13.4 Latin America Anti-Inflammatory Therapeutics Consumption Analysis from 2015-2020
13.5 Latin America Anti-Inflammatory Therapeutics Import and Export from 2015-2020
13.6 Latin America Anti-Inflammatory Therapeutics Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Anti-Inflammatory Therapeutics Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Anti-Inflammatory Therapeutics by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Anti-Inflammatory Therapeutics Sales by Country (2015-2020)
13.8.2 Latin America Anti-Inflammatory Therapeutics Consumption Value by Country (2015-2020)
13.9 Latin America Anti-Inflammatory Therapeutics Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Anti-Inflammatory Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Anti-Inflammatory Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Anti-Inflammatory Therapeutics Production Analysis from 2015-2020
14.4 Middle East & Africa Anti-Inflammatory Therapeutics Consumption Analysis from 2015-2020
14.5 Middle East & Africa Anti-Inflammatory Therapeutics Import and Export from 2015-2020
14.6 Middle East & Africa Anti-Inflammatory Therapeutics Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Anti-Inflammatory Therapeutics Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Anti-Inflammatory Therapeutics by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Anti-Inflammatory Therapeutics Sales by Country (2015-2020)
14.8.2 Middle East & Africa Anti-Inflammatory Therapeutics Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Anti-Inflammatory Therapeutics Market PEST Analysis
15 Future Forecast of the Global Anti-Inflammatory Therapeutics Market from 2020-2028
15.1 Future Forecast of the Global Anti-Inflammatory Therapeutics Market from 2020-2028 Segment by Region
15.2 Global Anti-Inflammatory Therapeutics Production and Growth Rate Forecast by Type (2020-2028)
15.3 Global Anti-Inflammatory Therapeutics Consumption and Growth Rate Forecast by Application (2020-2028)
16 Appendix
16.1 Methodology
16.2 Research Data Source
